Recent studies have demonstrated that GLP-1 therapy improves NK cell cytotoxicity
In comparison with naturally occurring receptor ligands, retatrutide has lower potency at the human glucagon and GLP-1 receptors, at approximately 0.3- and 0.4-fold, respectively, while showing markedly greater potency at the human GIP receptor, at about 8.9-fold
Understanding how these medications affect your body and taking proactive steps to manage side effects can help you use them safely and successfully under medical supervision
doi: 10.3389/fphys.2020.00012 26 HuoZ.YuL.YangJ.ZhuY.BennettD
Anyone considering an approved metabolic medicine should speak with a licensed medical professional
It sounds a cautionary note for short-term use without a more comprehensive approach to weight management.' Image source: West S, Scragg J, Aveyard P et al., The BMJ 2026 (CC BY 4.0) The Oxford team systematically reviewed 37 studies tracking more than 9,000 adults who stopped taking weight management medicines after being on them for an average of 39 weeks of treatment